RNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cells.


Journal

Nature cell biology
ISSN: 1476-4679
Titre abrégé: Nat Cell Biol
Pays: England
ID NLM: 100890575

Informations de publication

Date de publication:
04 2020
Historique:
received: 01 04 2019
accepted: 24 02 2020
pubmed: 2 4 2020
medline: 21 4 2020
entrez: 2 4 2020
Statut: ppublish

Résumé

The availability of nucleotides has a direct impact on transcription. The inhibition of dihydroorotate dehydrogenase (DHODH) with leflunomide impacts nucleotide pools by reducing pyrimidine levels. Leflunomide abrogates the effective transcription elongation of genes required for neural crest development and melanoma growth in vivo

Identifiants

pubmed: 32231306
doi: 10.1038/s41556-020-0493-0
pii: 10.1038/s41556-020-0493-0
pmc: PMC7185069
mid: NIHMS1566236
doi:

Substances chimiques

Dihydroorotate Dehydrogenase 0
Nucleotides 0
Phosphoproteins 0
Receptors, Progesterone 0
Transcription Factors 0
Zebrafish Proteins 0
Progesterone 4G7DS2Q64Y
Oxidoreductases Acting on CH-CH Group Donors EC 1.3.-
DDX1 protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13
ddx21 protein, zebrafish EC 3.6.4.13
Leflunomide G162GK9U4W

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

372-379

Subventions

Organisme : NIGMS NIH HHS
ID : P50 GM107618
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA103846
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA062220
Pays : United States

Références

White, R. M. et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518–522 (2011).
pubmed: 21430780 pmcid: 3759979 doi: 10.1038/nature09882
Lane, A. N. & Fan, T. W.-M. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 43, 2466–2485 (2015).
pubmed: 25628363 pmcid: 4344498 doi: 10.1093/nar/gkv047
Chabosseau, P. et al. Pyrimidine pool imbalance induced by BLM helicase deficiency contributes to genetic instability in Bloom syndrome. Nat. Commun. 2, 368 (2011).
pubmed: 21712816 doi: 10.1038/ncomms1363
Liu, W. et al. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc. Natl Acad. Sci. USA 109, 8983–8988 (2012).
pubmed: 22615405 doi: 10.1073/pnas.1203244109 pmcid: 3384197
Guo, J. & Price, D. H. RNA polymerase II transcription elongation control. Chem. Rev. 113, 8583–8603 (2013).
pubmed: 23919563 pmcid: 4294624 doi: 10.1021/cr400105n
Gressel, S. et al. CDK9-dependent RNA polymerase II pausing controls transcription initiation. eLife 6, e29736 (2017).
pubmed: 28994650 pmcid: 5669633 doi: 10.7554/eLife.29736
Peng, J., Liu, M., Marion, J., Zhu, Y. & Price, D. H. RNA polymerase II elongation control. Cold Spring Harb. Symp. Quant. Biol. 63, 365–370 (1998).
pubmed: 10384301 doi: 10.1101/sqb.1998.63.365
Adelman, K. & Lis, J. T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 13, 720–731 (2012).
pubmed: 22986266 pmcid: 3552498 doi: 10.1038/nrg3293
Tan, J. L. et al. Stress from nucleotide depletion activates the transcriptional regulator HEXIM1 to suppress melanoma. Mol. Cell 62, 34–46 (2016).
pubmed: 27058786 pmcid: 4836061 doi: 10.1016/j.molcel.2016.03.013
Luo, R., An, M., Arduini, B. L. & Henion, P. D. Specific pan-neural crest expression of zebrafish Crestin throughout embryonic development. Dev. Dyn. 220, 169–174 (2001).
pubmed: 11169850 doi: 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1
Jurynec, M. J. et al. The Paf1 complex and P-TEFb have reciprocal and antagonist roles in maintaining multipotent neural crest progenitors. Development 146, dev180133 (2019).
pubmed: 31784460 doi: 10.1242/dev.180133 pmcid: 6955205
Akanuma, T., Koshida, S., Kawamura, A., Kishimoto, Y. & Takada, S. Paf1 complex homologues are required for Notch-regulated transcription during somite segmentation. EMBO Rep. 8, 858–863 (2007).
pubmed: 17721442 pmcid: 1973952 doi: 10.1038/sj.embor.7401045
Yoo, H.-S., Seo, J.-H. & Yoo, J.-Y. CTR9, a component of PAF complex, controls elongation block at the c-Fos locus via signal-dependent regulation of chromatin-bound NELF dissociation. PLoS ONE 8, e61055 (2013).
pubmed: 23593388 pmcid: 3623864 doi: 10.1371/journal.pone.0061055
Cretekos, C. J. & Grunwald, D. J. alyron, an insertional mutation affecting early neural crest development in zebrafish. Dev. Biol. 210, 322–338 (1999).
pubmed: 10357894 doi: 10.1006/dbio.1999.9287
Rainger, J. et al. Miller (Genée–Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH. Hum. Mol. Genet. 21, 3969–3983 (2012).
pubmed: 22692683 doi: 10.1093/hmg/dds218
Read, L. D., Snider, C. E., Miller, J. S., Greene, G. L. & Katzenellenbogen, B. S. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol. Endocrinol. 2, 263–271 (1988).
pubmed: 3398853 doi: 10.1210/mend-2-3-263
Diep, C. H., Ahrendt, H. & Lange, C. A. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes. Steroids 114, 48–58 (2016).
pubmed: 27641443 pmcid: 5068826 doi: 10.1016/j.steroids.2016.09.004
Botos, J., Xian, W., Smith, D. F. & Smith, C. L. Progesterone receptor deficient in chromatin binding has an altered cellular state. J. Biol. Chem. 279, 15231–15239 (2004).
pubmed: 14744870 doi: 10.1074/jbc.M309718200
Calo, E. et al. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing. Nature 518, 249–253 (2015).
pubmed: 25470060 doi: 10.1038/nature13923
Calo, E. et al. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders. Nature 554, 112–117 (2018).
pubmed: 29364875 pmcid: 5927778 doi: 10.1038/nature25449
Xing, Y.-H. et al. SLERT regulates DDX21 rings associated with Pol I transcription. Cell 169, 664–678 (2017).
pubmed: 28475895 doi: 10.1016/j.cell.2017.04.011
Valvezan, A. J. et al. mTORC1 couples nucleotide synthesis to nucleotide demand resulting in a targetable metabolic vulnerability. Cancer Cell 32, 624–638 (2017).
pubmed: 29056426 pmcid: 5687294 doi: 10.1016/j.ccell.2017.09.013
Sarkar, M. & Ghosh, M. K. DEAD box RNA helicases: crucial regulators of gene expression and oncogenesis. Front. Biosci. 21, 225–250 (2016).
doi: 10.2741/4386
Sloan, K. E. et al. The association of late-acting snoRNPs with human pre-ribosomal complexes requires the RNA helicase DDX21. Nucleic Acids Res. 43, 553–564 (2015).
pubmed: 25477391 doi: 10.1093/nar/gku1291
Song, C., Hotz-Wagenblatt, A., Voit, R. & Grummt, I. SIRT7 and the DEAD-box helicase DDX21 cooperate to resolve genomic R loops and safeguard genome stability. Genes Dev. 31, 1370–1381 (2017).
pubmed: 28790157 pmcid: 5580657 doi: 10.1101/gad.300624.117
Kwak, H., Fuda, N. J., Core, L. J. & Lis, J. T. Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science 339, 950–953 (2013).
pubmed: 23430654 pmcid: 3974810 doi: 10.1126/science.1229386
Luengo, A., Gui, D. Y. & Vander Heiden, M. G. Targeting metabolism for cancer therapy. Cell Chem. Biol. 24, 1161–1180 (2017).
pubmed: 28938091 pmcid: 5744685 doi: 10.1016/j.chembiol.2017.08.028
Thisse, C. & Thisse, B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat. Protoc. 3, 59–69 (2008).
pubmed: 18193022 doi: 10.1038/nprot.2007.514
Thisse, B. & Thisse, C. In situ hybridization on whole-mount zebrafish embryos and young larvae. Methods Mol. Biol. 1211, 53–67 (2014).
pubmed: 25218376 doi: 10.1007/978-1-4939-1459-3_5
Kutner, R. H., Zhang, X.-Y. & Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4, 495–505 (2009).
pubmed: 19300443 doi: 10.1038/nprot.2009.22
Yuan, M., Breitkopf, S. B., Yang, X. & Asara, J. M. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 7, 872–881 (2012).
pubmed: 22498707 pmcid: 3685491 doi: 10.1038/nprot.2012.024
Link, V., Shevchenko, A. & Heisenberg, C.-P. Proteomics of early zebrafish embryos. BMC Dev. Biol. 6, 1 (2006).
pubmed: 16412219 pmcid: 1363346 doi: 10.1186/1471-213X-6-1
Bai, X. et al. TiF1-gamma plays an essential role in murine hematopoiesis and regulates transcriptional elongation of erythroid genes. Dev. Biol. 373, 422–430 (2013).
pubmed: 23159334 doi: 10.1016/j.ydbio.2012.10.008
Batsché, E., Yaniv, M. & Muchardt, C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat. Struct. Mol. Biol. 13, 22–29 (2006).
pubmed: 16341228 doi: 10.1038/nsmb1030
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
pubmed: 18798982 pmcid: 2592715 doi: 10.1186/gb-2008-9-9-r137
Ramírez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160–W165 (2016).
pubmed: 27079975 pmcid: 4987876 doi: 10.1093/nar/gkw257
Zarnegar, B. J. et al. irCLIP platform for efficient characterization of protein–RNA interactions. Nat. Methods 13, 489–492 (2016).
pubmed: 27111506 pmcid: 5477425 doi: 10.1038/nmeth.3840
Rappsilber, J., Friesen, W. J., Paushkin, S., Dreyfuss, G. & Mann, M. Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode. Anal. Chem. 75, 3107–3114 (2003).
pubmed: 12964758 doi: 10.1021/ac026283q
McAlister, G. C. et al. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal. Chem. 86, 7150–7158 (2014).
pubmed: 24927332 pmcid: 4215866 doi: 10.1021/ac502040v
Paulo, J. A. et al. Quantitative mass spectrometry-based multiplexing compares the abundance of 5000 S. cerevisiae proteins across 10 carbon sources. J. Proteomics 148, 85–93 (2016).
pubmed: 27432472 pmcid: 5035620 doi: 10.1016/j.jprot.2016.07.005
Bertrand, S. et al. Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression. PLoS Genet. 3, e188 (2007).
pubmed: 17997606 pmcid: 2065881 doi: 10.1371/journal.pgen.0030188
Wagner, D. E. et al. Single-cell mapping of gene expression landscapes and lineage in the zebrafish embryo. Science 360, 981–987 (2018).
pubmed: 29700229 pmcid: 6083445 doi: 10.1126/science.aar4362

Auteurs

Cristina Santoriello (C)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Audrey Sporrij (A)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Song Yang (S)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Ryan A Flynn (RA)

Department of Chemistry, Stanford University, Stanford, CA, USA.

Telmo Henriques (T)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.

Bilguujin Dorjsuren (B)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Eugenia Custo Greig (E)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Wyatt McCall (W)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Meredith E Stanhope (ME)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Maurizio Fazio (M)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Michael Superdock (M)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Asher Lichtig (A)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Isaac Adatto (I)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Brian J Abraham (BJ)

Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA, USA.

Marian Kalocsay (M)

Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.

Michael Jurynec (M)

Department of Orthopedics, University of Utah, Salt Lake City, UT, USA.

Yi Zhou (Y)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA.

Karen Adelman (K)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.

Eliezer Calo (E)

Department of Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.

Leonard I Zon (LI)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. leonard.zon@enders.tch.harvard.edu.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA, USA. leonard.zon@enders.tch.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH